Company Information

NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private
BSE198.90-1.65 (-0.82 %)
PREV CLOSE ( ) 200.55
OPEN PRICE ( ) 201.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2765
TODAY'S LOW / HIGH ( )198.80 203.00
52 WK LOW / HIGH ( )155.1 243.7
NSE199.05-2.2 (-1.09 %)
PREV CLOSE( ) 201.25
OPEN PRICE ( ) 204.00
BID PRICE (QTY) 199.05 (60)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 41635
TODAY'S LOW / HIGH( ) 198.25 205.35
52 WK LOW / HIGH ( )156.85 244.6
ChairmanSatish Kagliwal
Managing DirectorSatish Kagliwal
Company SecretaryDhiraj Rathi
Executive DirectorAkash Nandkishor Kagliwal
Jeevanlata Kagliwal
Independent Non-Executive DirectorVadla Nagbhushanam
Madhukar Deshpande
Ashu Jain
Hitesh Purohit
Incorporation Year : 13-09 2000

Registered Office :

Address : Nath House, Nath Road,P B No 318, Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431005 .

Phone : 0240-2376314/5/6/7

Industry : Agriculture

Listing : BSE,NSE,Ahmedabad

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.